Brain creatine kinase activity in an animal model of mania

Life Sciences

Volumn 82, Issue 7-8, 2008, Pages 424-429

  Streck, Emilio L ^a,c   Amboni, Graziela ^a,c   Scaini, Giselli ^a,c   Di Pietro, Priscila B ^a,c   Rezin, Gislaine T ^a,c   Valvassori, Samira S ^a,c   Luz, Gabrielle ^a,c   Kapczinski, Flávio ^b,c   Quevedo, João ^a,c  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Amphetamine; Bipolar disorder; Creatine kinase; Lithium; Mania; Valproate

Indexed keywords

AMPHETAMINE; CREATINE KINASE; LITHIUM; SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR MANIA; BRAIN REGION; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; LOCOMOTION; MALE; MANIA; NONHUMAN; RAT;

AMPHETAMINE; ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CREATINE KINASE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAPERITONEAL; LITHIUM COMPOUNDS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; VALPROIC ACID;

ANIMALIA; RATTUS;

EID: 39149116701     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.11.026     Document Type: Article

References (50)

1. Aksenov M., Aksenova M., Butterfield D.A., and Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. Journal of Neurochemistry 74 (2000) 2520-2527
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. (1994), American Psychiatric Association, Washington, D.C.
3. Anand A., Verhoeff P., Seneca N., Zoghbi S.S., Seibyl J.P., Charney D.S., and Innis R.B. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry 157 (2000) 1108-1114
4. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., and Caron M.G. Lithium antagonizes dopamine dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 5099-5104
5. Bell E.C., Willson M.C., Wilman A.H., Dave S., Asghar S.J., and Silverstone P.H. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Human Psychopharmacology 20 (2005) 87-96
6. Belmaker R.H. Bipolar disorder. New England Journal of Medicine 351 (2004) 476-486
7. Bessman S.P., and Carpenter C.L. The creatine-creatine phosphate energy shuttle. Annual Review of Biochemistry 54 (1985) 831-865
8. Bezchlibnyk Y., and Young L.T. The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Canadian Journal of Psychiatry 47 (2002) 135-148
9. Burbaeva G.S., Savushkina O.K., and Boksha I.S. Creatine kinase BB in brain in schizophrenia. World Journal of Biological Psychiatry 4 (2003) 177-183
10. Calabrese V., Scapagnini G., Giuffrida-Stella A.M., Bates T.E., and Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochemical Research 26 (2001) 739-764
11. Chang M.C., Contreras M.A., Rosenberger T.A., Rintala J.J., Bell J.M., and Rapoport S.I. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. Journal of Neurochemistry 77 (2001) 796-803
12. Chuang D.M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., and Leeds P. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disorders 4 (2002) 129-136
13. Corrêa C., Amboni G., Assis L.C., Frey B.N., Kapczinksi F., Streck E.L., and Quevedo J. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 887-891
14. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
15. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., and Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 61 (2004) 450-458
16. David S., Shoemaker M., and Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Research: Molecular Brain Research 54 (1998) 276-287
17. Deicken R.F., Weiner M.W., and Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. Journal of Affective Disorders 33 (1995) 195-199
18. Einat H., Yuan P., Gould T.D., Li J., Du J., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood regulation. Journal of Neuroscience 23 (2003) 7311-7316
19. Frey B.N., Martins M.R., Petronilho F.C., Dal-Pizzol F., Quevedo J., and Kapczinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as an animal model of mania. Bipolar Disorders 8 (2006) 275-280
20. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochemical Research 31 (2006) 699-703
21. Frey B.N., Andreazza A.C., Cereser K.M., Martins M.R., Valvassori S.S., Réus G.Z., Quevedo J., and Kapczinski F. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sciences 79 (2006) 281-286
22. Gandarias J.M., Echevarría E., Irazusta J., Múgica J., and Casis L. Effect of the acute administration of lithium on various enzymatic activities of the brain. Revista Española de Fisiología 45 (1989) 29-33
23. Gould T.D., and Manji H.K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 8 (2002) 497-511
24. Gross W.L., Bak M.I., Ingwall J.S., Arstall M.A., Smith T.W., Balligand J.L., and Kelly R.A. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 5604-5609
25. Hamman B.L., Bittl J.A., Jacobus W.E., Allen P.D., Spencer R.S., Tian R., and Ingwall J.S. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. American Journal of Physiology 269 (1995) 1030-1036
26. Hough C.J., and Chuang D.M. The mitochondrial hypothesis of bipolar disorder. Bipolar Disorders 2 (2000) 145-147
27. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clinica et Chimica Acta 7 (1962) 597-604
28. Jacobsen F.M. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. Journal of Clinical Psychiatry 54 (1993) 229-234
29. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2 (2000) 180-190
30. 7Li magnetic resonance spectroscopy. Journal of Affective Disorders 27 (1993) 53-59
31. Kato T., Inubushi T., and Kato N. Magnetic resonance spectroscopy in affective disorders. Journal of Neuropsychiatry and Clinical Neurosciences 10 (1998) 133-147
32. Khuchua Z.A., Qin W., Boero J., Cheng J., Payne R.M., Saks V.A., and Strauss A.W. Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues. Journal of Biological Chemistry 273 (1998) 22990-22996
33. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archives of General Psychiatry 61 (2004) 300-308
34. Kupfer D.J. The increasing medical burden in bipolar disorder. Journal of the American Medical Association 293 (2005) 2528-2530
35. Li X., Ketter T.A., and Frye M.A. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?. Journal of Affective Disorders 69 (2002) 1-14
36. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-267
37. MacDonald M.L., Naydenov A., Chu M., Matzilevich D., and Konradi C. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disorders 8 (2006) 255-264
38. Machado-Vieira R., Kapczinski F., and Soares J.C. Perspectives for the development of animal models of bipolar disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 (2004) 209-224
39. Mai L., Jope R.S., and Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. Journal of Neurochemistry 82 (2002) 75-83
40. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nature Medicine 7 (2001) 541-547
41. Saks V.A., Kuznetsov A.V., Kupriyanov V.V., Miceli M.V., and Jacobus W.E. Creatine kinase of rat heart mitochondria. The demonstration of functional coupling to oxidative phosphorylation in an inner membrane-matrix preparation. Journal of Biological Chemistry 260 (1985) 7757-7764
42. Schlattner U., and Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. Journal of Biological Chemistry 275 (2000) 17314-17320
43. Schnyder T., Gross H., Winkler H., Eppenberger H.M., and Wallimann T. Crystallization of mitochondrial creatine kinase. Growing of large protein crystals and electron microscopic investigation of microcrystals consisting of octamers. Journal of Biological Chemistry 266 (1991) 5318-5322
44. Stork C., and Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 10 (2005) 900-919
45. Strakowski S.M., and Sax K.W. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biological Psychiatry 44 (1998) 1171-1177
46. Sun X., Wang J.-F., Tseng M., and Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. Journal of Psychiatry and Neuroscience 31 (2006) 189-196
47. Tomimoto H., Yamamoto K., Homburger H.A., and Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathologica (Berlin) 86 (1993) 447-455
48. Wallimann T., Wyss M., Brdiczka D., Nicolay K., and Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochemical Journal 281 (1992) 21-40
49. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., Sharma V., Silverstone P., Alda M., Baruch P., Beaulieu S., Daigneault A., Milev R., Young L.T., Ravindran A., Schaffer A., Connoly M., and Gorman C.P. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 7 (2005) 5-69
50. Zugno A.I., Scherer E.B., Schuck P.F., Oliveira D.L., Wofchuk S., Wannmacher C.M., Wajner M., and Wyse A.T. Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum. Metabolic Brain Disease 21 (2006) 41-50